Search

Your search keyword '"Schmidt, Warren N"' showing total 120 results

Search Constraints

Start Over You searched for: Author "Schmidt, Warren N" Remove constraint Author: "Schmidt, Warren N" Language english Remove constraint Language: english
120 results on '"Schmidt, Warren N"'

Search Results

6. Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships

20. Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity.

24. Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection

27. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.

28. HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.

30. Finally sofosbuvir: an oral anti-HCV drug with wide performance capability.

32. Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.

39. Cell specificity of rat cytokeratin p39 during azo dye-induced hepatocarcinogenesis.

40. Cytokeratin and nonhistone protein antigenic changes in rat liver during azo dye but not hepatotoxin feeding.

46. 831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3.

47. Reply:.

49. S1001 Clearance of HCV At 5 Year Follow-Up for Peginterferon Alfa-2b ± Ribavirin Is Predicted By Sustained Virologic Response At 24 Weeks Post Treatment.

50. S1000 Results from the Epic3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the RE-Treatment of Previous Interferon/Ribavirin Non-Responders (Nr).

Catalog

Books, media, physical & digital resources